The Department of Health and Social Care recently published its National Genomic Healthcare Strategy, which the Association of the British Pharmaceutical Industry (ABPI) has acknowledged favourably.
Dr Bryan Deane, ABPI’s Director of New Medicines & Data Policy stated:
“You only have to look at the recent successes of genomics to see how far we’ve come – and the enormous future potential it holds for patients in both the prevention and treatment of all diseases. The UK has led the world in genomics, but if we want to maintain our place we need to build data infrastructure, skills and public trust ready for the next exciting decade.”
The Strategy is aimed at cementing the UK as the global leader in genomics and to create the most advanced genomic healthcare system in the world, centred around diagnosis and personalised medicine, prevention and research.
Further information about the National Genomic Healthcare Strategy can be accessed here.